CHELSEA ATKINSON: Open Payments
NPI 1578137253 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,320 in 149 payments from 24 companies in 2025. Trend: 2023 $1,958 · 2024 $3,412 · 2025 $5,320
Food & beverage: $3,995Travel & lodging: $1,325
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $2,003 |
| AstraZeneca Pharmaceuticals LP | 12 | $399 |
| Edwards Lifesciences Corporation | 7 | $388 |
| PFIZER INC. | 12 | $276 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $265 |
| Novartis Pharmaceuticals Corporation | 12 | $243 |
| E.R. Squibb & Sons, L.L.C. | 11 | $232 |
| Amgen Inc. | 11 | $195 |
| Merck Sharp & Dohme LLC | 9 | $183 |
| Novo Nordisk Inc | 9 | $168 |
Products named: NAVITOR, SAPIEN 3 Ultra RESILIA, JARDIANCE, ELIQUIS, LEQVIO, REPATHA, WAINUA, Wegovy.
Industry payments across SC — which companies pay providers there.
